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Abstract 
We have cloned a cDNA encoding the human ileal neurokinin-2 (NK-2) receptor which mediates powerful neurokinin A-stimulated arachidonic 
acid (AA) and prostaglandin release when expressed in CHO cells. Two major signal transduction events appear to underlie this response. Firstly, 
AA liberation is critically dependent upon agonist-stimulated influx of extracellular Ca’+ although not release from intracellular stores. Secondly, 
NK-2 receptor-linked AA mobilization requires concomitant PKC activation and based upon limited subtype immunodetectability as well as 
NKA-stimulated translocation, PKCa could play a major role. While NKA-stimulated Ca*+ mobilization is insensitive to preincubation with pertussis 
toxin, identical pretreatment inhibits AA release partially and blocks PKCa translocation completely. These observations indicate that in this cell 
system AA liberation reflects NK-2 receptor-dependent activation of two distinct but converging signal transduction pathways regulated by different 
G-protein species and involving Ca ‘* influx and PKCa activation. 
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1. Introduction 
Arachidonic acid (AA) as well as products of its oxida- 
tive metabolism (eicosanoids) are powerful local modu- 
lators of diverse physiological responses including 
smooth muscle contraction, renal absorption, sleep- 
wake cycles, hyperalgesia, neurotransmission and mito- 
genesis [l-5]. Eicosanoids have also been implicated in 
a number of inflammatory disease states [6,7]. Although 
many neurotransmitters and hormones stimulate en- 
hanced generation of eicosanoids through liberating AA, 
cellular mechanisms underlying this process are unclear. 
One important question relates to the pathways leading 
to activation of crucial phospholipases mobilizing mem- 
brane AA as this has been reported to reflect both direct 
G-protein coupling and indirect processes involving in- 
creased cytosolic Ca”, and/or phosphorylation [I ,3,8- 
I I]. It is unclear whether this reflects a redundancy of 
mechanisms with overlapping activities or whether dis- 
crete pathways predominate ither within different cellu- 
lar environments or to mediate the actions of specific 
receptors. 
Neurokinins (tachykinins) are a family of neuropep- 
tides dependent on cellular arachidonic acid mobiliza- 
tion for several important biological actions. They stim- 
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ulate eicosanoid generation in endothelium [12], macro- 
phages [ 131, astrocytes [ 141, rheumatoid synoviocytes 
[15] and heart [16] while blocking prostaglandin (PG) 
synthesis inhibits neurokinin-dependent spinal algesia 
[ 171, tracheal relaxation [ 181, control of myenteric cholin- 
ergic neurotransmission and colonic ion transport activ- 
ity [19,20]. As part of an investigation of mechanisms 
underlying neurokinin-stimulated eicosanoid generation 
we have cloned a human ileal NK-2 receptor and, follow- 
ing stable expression in CHO cells, identified early sig- 
nalling events crucial for AA liberation. We demonstrate 
that at least two distinct but converging NK-2 receptor- 
linked pathways, one involving Ca*’ influx the other 
PKCa: activation, play a major role mobilizing AA. 
2. Materials and methods 
2.1. Materials 
[5,6,8,9,11,12,14,15-‘HlArachidonic acid (180-240 Ci/mmol), prosta- 
glandin (PC) E, [‘*‘-Il-radioimmunoassay kits as well as ‘251-labelled 
sheep anti-mouse and anti-rabbit antibodies were purchased from New 
England Nuclear (Regensdorf, Switzerland). Dulbecco’s Modified 
Eagle’s Medium/Ham’s F-12 (DMEMIF-12) medium, fetal calf serum, 
monoclonal antibodies directed against PKC a, /?, @I and BII) and y 
peptide sequences as well as rabbit polyclonal antibodies against PKC 
6 and E were purchased from Gibco (Grand Island, NY, USA). Re- 
maining reagents were from the following companies: reduced strep- 
tolysin-0 from Wellcome Diagnostics (Dartford, UK), Fura 2-AM and 
BAPTA-AM from Calbiochem (La Jolla, CA, USA), organic solvents 
from Fluka (Buchs, Switzerland) and all other chemicals from Sigma 
(St. Louis, MO, USA). 
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2.2. NK-2 receptor cDNA clonmg and generation of cell lines 
The coding region of the rat NK-1 receptor gene was subcloned by 
PCR from a sample of rat brain mRNA using primers designed from 
the published sequence [21]. A cDNA bank in ilgtl0 consisting of 
4 x IO’ indeoendent nhage was constructed with mRNA isolated from 
a piece of human ileum. Approximately 1 x 10’ phage were screened at 
high stringency (hybridization, 20% formamide/ x SSC/42”C; wash, 
65”C/O.l x SSC) with the rat NK-1 cDNA radiolabeled by random 
priming (Boehringer-Mannheim). Inserts were isolated from positive 
phage and sequenced using standard techniques. The cDNA inserts 
were subcloned under the control of the HTLV-IILTR promoter in the 
mammalian expression vector pcDL-SRa296 [22] for recombinant ex- 
pression studies. CHO:DUKX-BI 1 cells devoid of endogenous dihy- 
drofolate reductase activity [23] were used as host cell for NK-2 recep- 
tor expression. The human NK-2 gene expression plasmid. pCDL/ 
hNK2, was co-transfected in a 9: 1 ratto with pNeo/DHFR, a plasmid 
containing the neomycin resistance gene and the dihydrofolate reduc- 
tase gene behind the adenovirus major late promoter. Recombinant 
transfectants were selected after 2 days in 0.6 mg/ml G418 (Geneticin. 
Gibco) and assayed after 12 days by flow cytometry (FACSCAN, 
Becton and Dickinson) using the tluorescein-labelled NKA [24]. Cells 
were grown in DMEM/FlZ supplemented with 10% fetal calf serum 
(Gibco). 2 mM glutamine, penicillin (200 IUlml) and streptomycin (200 
mg/ml) at 37°C and 5% CO,. Cells were routinely used for assays when 
80-90% confluent. 
2.3. Prostaglandrn Ez and [‘H]AA liberation 
Cells were cultured in 6-well plates (l-2 x lO’?well) and labelled for 
18 h by incubation using serum-f;ee DMEMIF-I2 containing fatty acid- 
free bovine serum albumin at 2 mg/ml (FAF-BSA) and [‘H]AA (0.5- 
1.0 $Yml). For stimulation. cells were washed three times with 2 ml 
of warmed PBS containing FAF-BSA and then incubated at 37°C for 
20 min under 5% CO2 in 1 ml of serum-free medium with FAF-BSA and 
stimulatory agents as indicated. Incubations were terminated by trans- 
ferring 800 ~1 to ice-cold tubes and centrifugation at 800 x g for 5 min 
after which aliquots were taken for either direct measurement of 
13H1AA release or for assay of PGE?. When permeabilization was per- 
formed cells grown m 6-well plates were incubated for 10 min with 
DMEMIF-12 containing FAF-BSA and 1.0 U/ml of reduced streptoly- 
sin-O. Cells were then washed twice and incubated for 20 min at 37°C 
m the same medium supplemented with 2 mM EGTA and concentra- 
tions of Car& to give free Ca” levels between IO-’ M and IO-’ M. 
2.4. Electrophoresls and immunoblotting 
Cells grown in 9-cm Petri dishes were stimulated with NKA, phorbol 
ester or A23187 in DMEM/F-12 containing FAF-BSA as indicated. 
Cells were then washed twice in ice-cold PBSand harvested by scraping 
and centrifugation at 200 x g for 5 min. Cells were resuspended in 0.5 
ml of 20 mM Tris, 2 mM EDTA, 10 mM EGTA, 5 mM DTT. 1 mg/ml 
leupeptin, 50 @ml aprotonin, 10 PM benzamidine, 0.5 mM phen- 
ylmethylsulfonyl f uoride (pH 7.5) and broken with a 30 s burst of an 
Ultra-Turrax homogenizer (Bender and Hobein, Zurich. Switzerland). 
Following centrifugation at 50,000 x g for 30 min at 4°C the supernat- 
ent was taken as CHOfI cell soluble fraction while the pellet was 
washed m 25 ml of the same buffer, re-centrifuged and suspended in 
0.5 ml of the same buffer containing 1% Triton X-100. Following 30 
min on ice the extract was centrifiged again at 50,000 x g and-the 
supernatent used as T&on-soluble membrane fraction. Protein extracts 
were separated by SDS-PAGE using 10% gels, transferred to nitrocel- 
luose membranes and immunoblot analysis performed as decribed [25]. 
3. Results and discussion 
Using a rat NK-1 gene probe, a human ileum cDNA 
library was screened and one phage with a 1.9 kbp inser- 
tion was found to contain the entire coding region for the 
human NK-2 receptor as published previously [27]. 
cDNA was transfected into Chinese hamster ovary cells 
(CHO/DUKX-Bll; see section 2) and one G418resis- 
tant cell population (CHO/T) selected for NK-2 receptor 
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Fig. 1. Ca” is a crucial determinant of [‘H]AA liberation from CHO/T 
cells. Prelabelled CHO/T cells were grown in 6-well plates and permea- 
bilized with reduced streptolysin-0. [“H]AA mobilization was measured 
following 20 min incubation at 37°C with free-Ca” levels between IO-’ 
M and 10-j M achieved by varying Car& concentrations in the presence 
of 2 mM EGTA. Points are the mean of 5 experiments each performed 
in triplicate. 
expression by flow cytometry using a fluorescent NKA 
peptide analogue. Binding of [‘“‘I]neurokinin A 
([“‘I]NKA) to CHO/T cells (not shown) indicated 28,000 
high-affinity sites/cell which was displaced by natural 
neurokinins with the rank-order NKA>NKB>>SP 
(NKA IC,, = 6 + 1 nM) consistent with expression of the 
NK-2 receptor subtype [28,29]. As observed for CHO 
cells expressing the bovine NK-2 receptor [26], CHO/T 
responded to NKA stimulation with increased [3H]AA 
and PGE, liberation (not shown) and these cells were 
employed for all studies described here. 
In contrast to our previous report that NK-2 receptor- 
linked IP, generation is GTP-dependent in streptolysin- 
0 permeabilized CHO cells [26], NKA and GTPyS fail 
to stimulate [3H]AA mobilization under identical condi- 
tions at any concentration of free Ca’+ between 10m7 M
and 10m3 M (data not shown). This suggests that rather 
than direct G-protein coupling, NK-2 receptor stimu- 
lated AA liberation reflects, at least in part, indirect sig- 
nalling processes critically dependent upon an intact cell 
enviroment. Fig. 1 shows that in permeabilized cells 
physiologically relevant concentrations of free Ca’+ trig- 
ger increased [3H]AA mobilization by up to 232 + 32% 
(n = 5) suggesting that increased cytosolic Ca” could 
normally be an important signal. Since NK-2 receptors 
expressed in CHO cells are known to mobilize Ca” [26], 
we employed conditions optimized to inhibit selectively 
either receptor-linked Ca2’ influx or its liberation from 
S. Arkinstall et al. IFEBS Letters 338 (1994) 75-80 
-11 -10 -9 -8 -7 -6 -5 -4 
Log NKA Concentration 
(Molar) 
IE 
10000 
; 8000 
5 
z 6000 
g 4000 
< 
I 
2 2000 
- I 
o+ 
-11 
T 
& )_” BAPTA_ 
-10 -8 -8 -7 -6 -5 -4 
Log NKA Concentration 
(Molar) 
1-----‘- 1/T ---_I I ’ 
Fig. 2. Ca2’ is a crucial determinant of [‘H]AA liberation from CHO/T cells. Prelabelled CHO/T cells were grown in 6-well plates and [‘H]AA liberation 
measured following stimulation with increasing concentrations of NKA for 20 min at 37°C in the presence of 1 mM free Cal’, following Ca” chelation 
with 2 mM EGTA, or after addition of 2 mM EGTA/3 mM CaCl, (A). In similar experiments [‘H]AA release was tested with 1 PM extracellular 
Ca2’ after loading cells with the intracellular chelator BAPTA-AM (50 ,uM for 5 min) (B). Points are the mean of 3 (A) or 5 (B) experiments each 
performed in triplicate. 
intracellular stores (not shown) to test which of these 
Ca2+ components is quantitatively more important for 
[3H]AA liberation. While blocking NKA-stimulated 
Ca*+ influx using extracellular EGTA (2 mM, added ~2 
min before stimulation) abolished NK-2 receptor-linked 
[3H]AA mobilization, supplementing medium with 3 mM 
CaCl, restored cellular responsiveness (Fig. 2A) suggest- 
ing that extracellular Ca2’ plays a crucial role. Surpris- 
ingly, loading cells with the chelator BAPTA-AM (50 
PM; pretreatment for 5 min) to abolish rapid NKA- 
stimulated Ca2’ mobilization did not effect NKA-stimu- 
lated [3H]AA release (Fig. 2B). These results suggest hat 
NKA-stimulated Ca2’ influx and not release from intra- 
cellular stores is a major trigger mediating [3H]AA liber- 
ation. 
Stimulation of NK-2 receptors expressed in CHO cells 
is reported to increase phospholipase (PL) C-dependent 
phosphoinositide hydrolysis [26,29,30]. One likely conse- 
quence of this hydrolytic reaction is activation of PKC 
[31] which is an additional potentially important early 
step in processes leading to AA liberation. To test this 
we employed two treatments optimized to inhibit en- 
dogenous PKC activities in intact CHO/T cells (data not 
shown). Following either treatment with staurosporine 
( 10m6 M for 15 min) or long-term exposure to phorbol 
ester (10M6 M PMA for 18 h), NKA-stimulated [3H]AA 
mobilization was suppressed by-50% (Fig. 3A). A general 
inhibitory effect on NK-2 receptor-linked signalling and 
phospholipase activation is unlikely as NKA stimulated 
[3H]inositol phosphate generation is increased by up to 
5-fold following identical pretreatment (data not shown). 
These observations upport a central role for PKC in an 
NK-2 receptor-linked pathway liberating AA. 
Molecular cloning indicates that mammalian PKC ex- 
ists as a large family consisting of at least 10 subspecies 
with closely related structures. These have been subdi- 
vided into Ca*‘-sensitive (PKCa, /?I, /III and y) and 
Ca2’-independent (PKCG, E, C, q, 8 and 1) isoforms with 
different activation requirements, kinetic properties, 
substrate specificities, tissue distribution and subcellular 
localization [31]. To test which of these subtypes are 
expressed in CHO/T cells as well as which are regulated 
by the NK-2 receptor and could be involved in AA mo- 
bilization we have employed specific antibodies for im- 
munoblot analysis. While isoforms /? (either PI and /III), 
y and E were not detectable by this approach, bands of 
expected molecular weight (-80 kDa) were observed using 
antibodies selective for PKCcl (Fig. 4A) and PKCS (not 
shown). PKC activation is characterized by transloca- 
tion from cytosolic to particulate fractions and such a 
relocalization of PKCa was observed following stimula- 
tion with either NKA or phorbol ester (Fig. 4A). Al- 
though PKCS was found localized in both particulate 
and soluble fractions in resting cells, low expression lev- 
els prevented clear assessment of whether this distribu- 
tion is sensitive to NKA stimulation. Increased mem- 
brane association was however observed in the presence 
of phorbol ester (not shown). Together these observa- 
tions suggest that PKC plays a role mediating NKA- 
stimulated AA liberation and that PKC subtypes 6 and 
78 
particularly 01 are potential mediators of this response. 
Such a conclusion is not restricted to NK-2 receptors in 
CHO cells as PKCcl has also been proposed as the major 
isoform mediating bradykinin-stimulated AA release in 
MDCK cells [32] while heterologous expression of this 
PKC subtype facilitates considerably PDGF-stimulated 
AA efflux in NIH 3T3 fibroblasts [33]. 
Although these observations implicate PKC as a medi- 
ator of AA liberation in CHO cells, we were surprised 
to find that stimulation with PMA under conditions me- 
diating PKCa and S translocation (Fig 4A) failed to 
enhance [3H]AA release (Fig. 5). In the presence of the 
calcium-ionophore A23 187, however (which alone stim- 
ulated [3H]AA liberation by -14-fold), phorbol ester aug- 
ments [3H]AA release up to -35-fold above basal levels 
with half maximal effect observed at 3 nM PMA (Fig. 
5). NKA mimicks this A23187 action to augment PMA- 
stimulated [3H]AA output although effective phorbol 
ester concentrations are -lo-fold higher (Fig. 5). This syn- 
ergistic stimulation of [3H]AA output reflects concomi- 
tant Ca2’ mobilization and PKC activation. Hence, 2 
mM EGTA abolished all stimulatory actions in the pres- 
ence of A23187 while supplementing with excess CaCl, 
(3 mM) restored full responsiveness (data not shown). In 
addition, all PMA actions were abolished following 18 
h incubation with low6 M phorbol ester to down regulate 
PKC (Fig. : 5). Interestingly, PKC down-regulation also 
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inhibited A23 187-stimulated [3H]AA release by 
63 ? 6.0% (n = 6) (Fig. 5) suggesting that as well as 
PMA, a large proportion of ionophore action reflects 
PKC activation. This is consistent with A23187-stimu- 
lated translocation of PKCcl from cytosolic to mem- 
brane fractions (Fig. 4A). These observations demon- 
strate that although PKC activation is an important 
component in mediating NKA-stimulated [3H]AA liber- 
ation, this effect is crucially dependent upon concomi- 
tant Ca2+ influx. 
A further interesting observation in our cell system 
was that pretreatment with pertussis toxin under condi- 
tions which maximally ADP-ribosylate G-proteins en- 
dogenous to CHO/T cells [26] blocks totally NKA-stim- 
ulated PKCa translocation (Fig. 4B). This is consistent 
with an important role for pertussis toxin sensitive 
PKCcl activation in mediating NK-2 receptor-dependent 
[‘H]AA liberation as this was also inhibited by 73 ? 5.0% 
(n = 4) following identical pretreatment (Fig. 3B). Im- 
portantly, inhibition of AA release following combined 
pretreatment with pertussis toxin and PMA to down 
regulate PKC is no greater than with either agent acting 
alone (Fig. 3B). It is of note that as reported previously 
for NK-2 receptor-linked IP, generation [26], both Ca2’ 
influx and mobilization from intracellular stores are in- 
sensitive to CHO/T cell pretreatment with pertussis toxin 
(data not shown). This indicates that similar to muscar- 
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Fig. 3. Inhibition of NKA-stimulated [3H]AA generation following pretreatment with phorbol ester, staurosporine or pertussis toxin. CHO/T cells 
grown in 6-well plates were prelabelled and NKA-stimulated [jH]AA liberation measured for 20 min after pretreatment with either 1 /LM PMA for 
18 h, 1 PM staurosporine for 15 min (A) or with pertussis toxin (PTx; 500 ng/ml for 18 h) with and without PMA (1 ,uM PMA for 18 h) (B). Bars 
represent the mean f S.D. of 4 experiments each performed in triplicate. 
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Fig. 4. Immunodetection of PKCu and 6 in CHOfT cell extracts. CHO/T cells grown in 9 cm Petri dishes were stimulated with NKA (1 PM), PMA 
(0.1 PM) or A23187 (A23; 10 PM) for 20 min at 37’C and cell soluble and membrane fractions analysed by SDS-PAGE and immunoblotting with 
PKCa-selective antibodies as described in section 2. Where indicated cells were pretreated with pertussis toxin (PTX) at 500 @ml for 18 h. 
inic and metabotropic glutamate receptors expressed in 
CHO cells [34,35], human NK-2 receptors interact with 
multiple G-proteins to activate independent second mes- 
senger responses (Ca2+ influx and PKCa activation) 
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which converge at a level crucial in processes mediating 
AA liberation. While G-proteins of the G, class are ex- 
pressed in CHO cells [36] and are likely candidates medi- 
ating pertussis toxin insensitive NK-2 receptor-linked 
phosphoinositide hydrolysis and Ca2’ mobilization [26], 
G,, is important for AA release in this cell type [37] and 
could underly pertussis toxin sensitive events such as 
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